Characterization of β ‐adrenoceptor mediated smooth muscle relaxation and the detection of mRNA for β 1 ‐, β 2 ‐ and β 3 ‐adrenoceptors in rat ileum
Authors:
- 1 June 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 127 (4) , 949-961
Abstract
Functional and molecular approaches were used to characterize the β‐AR subtypes mediating relaxation of rat ileal smooth muscle. In functional studies, (−)‐isoprenaline relaxation was unchanged by CGP20712A (β 1 ‐AR antagonist) or ICI118551 (β 2 ‐AR antagonist) but shifted by propranolol (pK B =6.69). (±)‐Cyanopindolol, CGP12177 and ICID7114 did not cause relaxation but antagonized (−)‐isoprenaline relaxation. BRL37344 (β 3 ‐AR agonist) caused biphasic relaxation. The high affinity component was shifted with low affinity by propranolol, (±)‐cyanopindolol, tertatolol and alprenolol. CL316243 (β 3 ‐AR agonist) relaxation was unaffected by CGP20712A or ICI118551 but blocked by SR58894A (β 3 ‐AR antagonist; pA 2 =7.80). Enhanced relaxation after exposure to forskolin and pertussis toxin showed that β 3 ‐AR relaxation can be altered by manipulation of components of the adenylate cyclase signalling pathway. The β 1 ‐AR agonist RO363 relaxed the ileum (pEC 50 =6.18) and was blocked by CGP20712A. Relaxation by the β 2 ‐AR agonist zinterol (pEC 50 =5.71) was blocked by SR58894A but not by ICI118551. In rat ileum, β 1 ‐, β 2 ‐ and β 3 ‐AR mRNA was detected. Comparison of tissues showed that β 3 ‐AR mRNA expression was greatest in WAT>colon=ileum>cerebral cortex>soleus; β 1 ‐AR mRNA was most abundant in cerebral cortex>WAT>ileum=colon>soleus; β 2 ‐AR mRNA was expressed in soleus>WAT>ileum=colon>cerebral cortex. These results show that β 3 ‐ARs are the predominant β‐AR subtype mediating rat ileal relaxation while β 1 ‐ARs may produce a small relaxation. The β 2 ‐AR agonist zinterol produces relaxation through β 3 ‐ARs and there was no evidence for the involvement of β 2 ‐ARs in relaxation despite the detection of β 2 ‐AR mRNA. British Journal of Pharmacology (1999) 127 , 949–961; doi: 10.1038/sj.bjp.0702605Keywords
This publication has 41 references indexed in Scilit:
- Functional and molecular evidence for β1‐, β2‐ and β3‐adrenoceptors in human colonBritish Journal of Pharmacology, 1997
- Effects of (−)‐RO363 at human atrial β‐adrenoceptor subtypes, the human cloned β3‐adrenoceptor and rodent intestinal β3‐adrenoceptorsBritish Journal of Pharmacology, 1997
- β‐Adrenoceptors regulate myoelectric activity in the small intestine of rats: stimulation by β2and inhibition by β3subtypesNeurogastroenterology & Motility, 1996
- Contributions of β-Adrenoceptor Subtypes to Responses to Isoprenaline in Rat Isolated Distal ColonJournal of Pharmacy and Pharmacology, 1995
- Distribution of β3-adrenoceptor mRNA in human tissuesEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Interaction of tertatolol at the “atypical” or beta3-adrenoceptor in guinea-pig ileumGeneral Pharmacology: The Vascular System, 1992
- Labelling of Rat Brain ß-Adrenoceptors: (3H)CGP-12177 or (125I)Iodocyanopindolol?Journal of Receptor Research, 1992
- Decreased gastro-intestinal responses to salbutamol and serotonin in streptozotocin-induced diabetes: Improving effect of insulin in vivo and in vitroGeneral Pharmacology: The Vascular System, 1988
- Decreased Gastro-intestinal Responses to Certain Agonists in Streptozotocin- and Alloxan-Diabetic Rats in vitroPharmacology, 1987
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967